-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Aldeyra Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
- Aldeyra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.23M, a 309% increase year-over-year.
- Aldeyra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $5.91M, a 37% decline year-over-year.
- Aldeyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.75M, a 30.6% decline from 2022.
- Aldeyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.29M, a 16.6% increase from 2021.
- Aldeyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.11M, a 0.34% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)